⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PDSB News
PDS Biotechnology Corporation Common Stock
PDS Biotech Reports Second Quarter 2026 Financial Results
globenewswire.com
PDSB
Form 8-K
sec.gov
PDSB
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
globenewswire.com
PDSB
Form 8-K
sec.gov
PDSB
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
CUE
GMAB
IMPP
INO
AZN
GSK
MRK
BMY
EXEL
REGN
PDSB
IOVA
RPTX
Form 8-K
sec.gov
PDSB
Form 8-K
sec.gov
PDSB
Form 8-K
sec.gov
PDSB
Form 8-K
sec.gov
PDSB